1,008 followers
Congratulations to Neeraj Narula and research team on their public disclosure, "End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis." https://t.co/2iI6KzH9B2